Biora Therapeutics, Inc. (BIOR)
Largest Insider Buys in Sector
BIOR Stock Price History Chart
BIOR Stock Performance
About Biora Therapeutics, Inc.
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract …
Insider Activity of Biora Therapeutics, Inc.
Over the last 12 months, insiders at Biora Therapeutics, Inc. have bought $0 and sold $0 worth of Biora Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Biora Therapeutics, Inc. have bought $15,640.69B and sold $4,585 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,012,500 shares for transaction amount of $46,921.89B was made by Athyrium Opportunities III Co-Invest 1 LP (director) on 2022‑11‑09.
List of Insider Buy and Sell Transactions, Biora Therapeutics, Inc.
| 2022-11-09 | director | 25.01M – | $1.88M | $46,921.89B | -45.65% | |||
| 2022-07-05 | Sale | 7,517 0.052% | $0.61 | $4,585 | -70.67% | |||
| 2021-06-14 | 10 percent owner | 8.1M – | $2.47 | $20M | -49.53% | |||
| 2021-06-14 | 10 percent owner | 8.1M – | $2.47 | $20M | -49.53% | |||
| 2021-06-01 | 10 percent owner | 961,807 31.1904% | $2.86 | $2.75M | -40.91% | |||
| 2021-06-01 | 10 percent owner | 961,807 31.1904% | $2.86 | $2.75M | -40.91% | |||
| 2020-12-16 | Chief Operating Officer | 58,081 3.0145% | $4.58 | $265,857 | -33.01% | |||
| 2020-12-15 | Chief Operating Officer | 63,870 2.9475% | $4.07 | $259,951 | -24.88% | |||
| 2020-12-14 | director | 20,000 1.0999% | $4.85 | $97,000 | -24.21% | |||
| 2020-12-07 | 10 percent owner | 4.13M – | $3.27 | $13.5M | -9.86% | |||
| 2020-12-07 | 10 percent owner | 4.13M – | $3.27 | $13.5M | -9.86% | |||
| 2020-12-02 | Chairman & CEO | 152,905 5.6694% | $3.27 | $499,999 | -2.89% | |||
| 2020-09-03 | Chief Scientific Officer | 9,151 0.8872% | $8.55 | $78,241 | -50.06% | |||
| 2020-09-02 | Chief Scientific Officer | 99 0.0096% | $8.55 | $846 | -53.78% | |||
| 2020-08-19 | Chairman & CEO | 10,000 1.0137% | $8.94 | $89,400 | -50.40% | |||
| 2020-06-23 | 10 percent owner | 3.33M – | $15.00 | $50M | -50.62% | |||
| 2020-06-23 | 10 percent owner | 3.33M – | $15.00 | $50M | -50.62% | |||
| 2020-06-19 | Chairman & CEO | 33,333 5.6693% | $15.00 | $499,995 | -57.16% | |||
| 2013-07-15 | 10 percent owner | 5,000 0.0079% | $0.14 | $700 | ||||
| 2013-07-12 | 10 percent owner | 1,933 0.0028% | $0.13 | $251 |